Oncologist-Patient Concordance and Treatment Adherence in Chronic Myeloid Leukemia

This cohort study investigates the association between oncologist-patient demographic concordance and adherence to tyrosine kinase inhibitor treatment in chronic myeloid leukemia.

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2025-04-30
DOI
https://doi.org/10.1001/jamanetworkopen.2025.8039
Citations
3
Primary Topic
Chronic Myeloid Leukemia Treatments
Type
article
Field-Weighted Citation Impact
5.31

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Oncologist-Patient Concordance and Treatment Adherence in Chronic Myeloid Leukemia

J. Felipe Montano-Campos, Eric C. Haupt, Erin Elizabeth Hahn, Aasthaa Bansal et al.
3 citations
JAMA Network Open
Chronic Myeloid Leukemia Treatments
5.31
article

Oncologist-Patient Concordance and Treatment Adherence in Chronic Myeloid Leukemia

J. Felipe Montano-Campos, Eric C. Haupt, Erin Elizabeth Hahn, Aasthaa Bansal, Jerald P. Radich
article en
3 citations

Abstract

This cohort study investigates the association between oncologist-patient demographic concordance and adherence to tyrosine kinase inhibitor treatment in chronic myeloid leukemia.

JAMA Network OpenVol. 8(4)
Kaiser Permanente (US), University of Washington (US), University of Washington Medical Center (US), Fred Hutch Cancer Center (US)
National Institutes of Health, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 5%
Chronic Myeloid Leukemia Treatments
5.31
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.